Discover the latest software purchases and digital transformation initiatives being undertaken by New York Allergy and Sinus Group, PLLC and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 150 New York Allergy and Sinus Group, PLLC employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that New York Allergy and Sinus Group, PLLC has purchased the following applications: AdvancedMD for Medical Practice Management in 2009 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems New York Allergy and Sinus Group, PLLC is running and its propensity to invest more and deepen its relationship with AdvancedMD or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing New York Allergy and Sinus Group, PLLC revenues, which have grown to $30.0 millions in 2019, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for New York Allergy and Sinus Group, PLLC intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.